University of Wollongong
Browse

Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms

Download (1.81 MB)
journal contribution
posted on 2024-11-16, 06:54 authored by Amy Wyatt, Patrick Constantinescu, Heath EcroydHeath Ecroyd, Christopher M Dobson, Mark WilsonMark Wilson, Janet R Kumita, Justin YerburyJustin Yerbury
α2-Macroglobulin (α2M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α2M with proteases results in an ‘activated’ conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α2M. This study investigates, the effect of activation on the ability of α2M to inhibit amyloid formation by Aβ1–42 and I59T human lysozyme and shows that protease-activated α2M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway.

Funding

The role of clusterin in preventing atherosclerosis

National Health and Medical Research Council

Find out more...

Small heat shock proteins: front-line defenders and therapeutic targets

Australian Research Council

Find out more...

History

Citation

Wyatt, A. R., Constantinescu, P., Ecroyd, H., Dobson, C. M., Wilson, M. R., Kumita, J. R. & Yerbury, J. J. (2013). Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms. FEBS Letters, 587 (5), 398-403.

Journal title

FEBS Letters

Volume

587

Issue

5

Pagination

398-403

Language

English

RIS ID

75822

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC